Related Experiment Videos
Splenic visualization using 99mTc-methylene diphosphonate in a patient with sickle cell disease
Clinical Nuclear Medicine
|August 1, 1978
Summary
Bone-seeking agents like 99mTc-MDP can visualize the spleen in sickle cell disease patients, indicating splenic infarction and calcification. This method aids in monitoring functional auto-splenectomy and detecting splenic tissue not seen on sulfur colloid scans.
Area of Science:
- Nuclear medicine
- Radiopharmaceuticals
- Pediatric imaging
Background:
- Sickle cell disease (SCD) frequently leads to splenic dysfunction and infarction, a process termed functional auto-splenectomy.
- Standard liver/spleen scans using sulfur colloid may fail to visualize the spleen in advanced SCD.
- Assessing splenic status is crucial for managing SCD complications.
Observation:
- A 15-year-old boy with sickle cell crisis showed splenic uptake of 99mTc-methylene diphosphonate (99mTc-MDP), a bone-seeking agent.
- Simultaneously, there was an absence of splenic uptake on a sulfur colloid liver/spleen scan.
- This discrepancy suggests splenic infarction and calcification.
Findings:
- Splenic visualization with 99mTc-MDP in SCD indicates splenic infarction and calcification.
- This finding may represent splenic tissue not detected by conventional sulfur colloid scans.
- The uptake pattern is likely due to microvascular occlusion and subsequent calcification within the spleen.
Implications:
- 99mTc-MDP splenic visualization offers a sensitive method for monitoring the progression of functional auto-splenectomy in sickle cell disease.
- It can help detect residual splenic tissue when standard scans are negative.
- This technique should be differentiated from skeletal lesions or abdominal masses to avoid misdiagnosis.